Structure Therapeutics: Pay

Structure Therapeutics paid its 5 named executives $20.6M in total in FY2025 (Dec). CEO Raymond Stevens, Ph.D. was paid $8.4M of that.

Pay$100 in the stock at the end of FY23 → $171
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Raymond Stevens, Ph.D.Chief Executive Officer and Director
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Jun YoonChief Financial Officer
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
3 years
Blai Coll, M.D., Ph.D.Chief Medical Officer
FY2025 (Dec)
FY2024 (Dec)Not disclosed
2 years
Xichen Lin, Ph.D.Chief Scientific Officer
FY2025 (Dec)
FY2024 (Dec)Not disclosed
2 years
Yingli Ma, Ph.D.Chief Technology Officer
FY2025 (Dec)
1 year

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 7 peers with pay on file was $9.7M. The CEO of Structure Therapeutics was paid $8.4M, 13% below the median.

  1. 1Madrigal Pharmaceuticals
  2. 2Revolution Medicines
  3. 3Disc Medicine
  4. 4Arcus Biosciences
  5. 5IDEAYA Biosciences
  6. 6Structure Therapeutics
  7. 7Denali Therapeutics
  8. 8Keros Therapeutics
  9. 989bio, Inc.Not disclosed
  10. 10Akero Therapeutics, Inc.Not disclosed
  11. 11Arrowhead PharmaceuticalsNot disclosed
  12. 12BiohavenNot disclosed
  13. 13Crinetics Pharmaceuticals, Inc.Not disclosed
  14. 14Dianthus Therapeutics, Inc.Not disclosed
  15. 15Longboard Pharmaceuticals, Inc.Not disclosed
  16. 16Morphic Holding, Inc.Not disclosed
  17. 17Pliant Therapeutics, Inc.Not disclosed
  18. 18VaxcyteNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.